| Code | 7694D | ||||||||||
| MA number | 19/0141/21-S | ||||||||||
| Product Form: | tbl flm 30x360 mg (blis.PVC/PVDC/Al) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Mutual recognition procedure | ||||||||||
| Therapeutic Class: | 19 - ANTIDOTA, DETOXICANTIA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | blister PVC/PVDC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 26.05.2021 |
| Validity: | 26.05.2026 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Deferasirox Zentiva 360mg_tbl flm_04_2024.pdf
|
| SPC: |
SPC_Deferasirox Zentiva 360 mg_tbl flm_04_2024.pdf
|
| Safety feature | Yes |
| Data update: | 27.05.2021 |
